Autophagy inhibition enabled efficient photothermal therapy at a mild temperature

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Nanomaterial-mediated photothermal therapy faces challenges due to uneven heat distribution, leading to incomplete tumor eradication and healthy tissue damage.
• Autophagy, a cellular process, is activated in cancer cells during photothermal therapy, potentially hindering treatment efficacy.

Purpose of the Study:

• To investigate the role of autophagy in photothermal therapy.
• To develop a novel formulation for enhanced photothermal cancer therapy by inhibiting autophagy.

Main Methods:

• Development of chloroquine-loaded polydopamine nanoparticles.
• In vitro and in vivo studies to evaluate the efficacy of the developed nanoparticles in photothermal therapy.
• Assessment of autophagy inhibition's impact on cancer cell killing and tumor suppression.

Main Results:

• Autophagy activation was observed in cancer cells undergoing photothermal therapy.
• Inhibition of autophagy significantly enhanced the cancer cell killing efficacy.
• Chloroquine-loaded polydopamine nanoparticles demonstrated remarkable augmentation of photothermal therapy efficacy, leading to efficient tumor suppression at mild temperatures.

Conclusions:

• Autophagy inhibition is a viable strategy to improve photothermal cancer therapy outcomes.
• The developed chloroquine-loaded polydopamine nanoparticles offer a promising approach for sensitized photothermal cancer treatment.
• Targeting autophagy provides a new therapeutic route for more effective cancer treatment.